| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 6 |
| 1 | PEMBROLIZUMAB | 4 |
| 2 | AXITINIB | 1 |
| 3 | CYCLOPHOSPHAMIDE | 1 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1 |
| 6 | DOXORUBICIN | 1 |
| 7 | DULAGLUTIDE | 1 |
| 8 | GOSERELIN | 1 |
| 9 | HYDROXYCHLOROQUINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OSILODROSTAT | 1 | 0.0005 |
| 1 | GOSERELIN | 1 | 0.0001 |
| 2 | NIVOLUMAB | 6 | 0.0001 |
| 3 | AXITINIB | 1 | 0.0001 |
| 4 | INSULIN DEGLUDEC | 1 | 0.0000 |
| 5 | PEMBROLIZUMAB | 4 | 0.0000 |
| 6 | INSULIN HUMAN | 1 | 0.0000 |
| 7 | PIOGLITAZONE | 1 | 0.0000 |
| 8 | IPILIMUMAB | 1 | 0.0000 |
| 9 | LETROZOLE TABLETS | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 |
| 1 | Alkylating Drug [EPC] | 1 |
| 2 | Aromatase Inhibitor [EPC] | 1 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 |
| 4 | Corticosteroid [EPC] | 1 |
| 5 | GLP-1 Receptor Agonist [EPC] | 1 |
| 6 | Insulin Analog [EPC] | 1 |
| 7 | Insulin [EPC] | 1 |
| 8 | Kinase Inhibitor [EPC] | 1 |
| 9 | Microtubule Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |
| 1 | Insulin [EPC] | 1 | 0.0000 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 4 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 7 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Insulin Analog [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 1 | 0.0000 |